SCHEMBL8308640

SCHEMBL8308640

CCCCCCOC(=O)/N=C(\N)c1ccc(O)c(CNc2ncnc3cc(C(=O)N4CCCC4)c(Cl)cc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 3/20 0.37
CNR1 P21554 1/20 0.34
NR1I2 O75469 1/20 0.34
F2 P00734 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
SLC6A2 P23975 1/20 0.34
AGTR1 P30556 1/20 0.34
SLC6A3 Q01959 1/20 0.34
SCN5A Q14524 1/20 0.34
EGFR P00533 4/20 0.33
KDR P35968 2/20 0.33
PDE5A O76074 2/20 0.33
SMYD3 Q9H7B4 1/20 0.33
ALDH1A1 P00352 4/20 0.32
HPGD P15428 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ERBB2 P04626 2/20 0.32
HDAC3 O15379 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8312245 0.90 HPGD (0.36) CDK1CNR1NR1I2F2ADORA3
SCHEMBL6325719 0.86 CNR1 (0.47) CDK1CNR1EGFRKDRPDE5A
SCHEMBL8311630 0.85 CDK1 (0.42) CDK1CNR1EGFRPDE5AALDH1A1
SCHEMBL8309844 0.84 CDK1 (0.34) CDK1CNR1EGFRKDRPDE5A
SCHEMBL8312247 0.83 CDK1 (0.39) CDK1CNR1EGFRPDE5AALDH1A1
SCHEMBL6326778 0.82 CDK1 (0.41) CDK1CNR1PDE5AALDH1A1HPGD
SCHEMBL8308730 0.81 PDE5A (0.36) CDK1EGFRPDE5AALDH1A1HPGD
SCHEMBL2995398 0.81 CDK1 (0.42) CDK1CNR1PDE5AALDH1A1HPGD
SCHEMBL8312292 0.77 CDK1 (0.36) CDK1EGFRPDE5AALDH1A1HPGD
SCHEMBL6326818 0.77 CDK1 (0.47) CDK1CNR1PDE5AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004080970-A1 NOVEL BICYCLIC AROMATIC COMPOUNDS, THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-09-23 WO disclosed